Reports

Ideas That Generate Results

Booming Generics Drug Market in India

Booming Generics Drug Market in India

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Aug, 2011| No. of Pages : 60

Share |
 
Please make your selection :
Electronic Access - Single User License
US$ 1000.00  600.00
CD-ROM Mail Delivery
US$ 1200.00  650.00
Hard Copy Mail Delivery
US$ 1200.00  700.00
Electronic Access - Multi-User License
US$ 1800.00  750.00

1. Analyst View

2. Research Methodology

3. Indian Generics Market - An Overview

4. Key Market Drivers
     4.1 Increasing Export
     4.2 Private Investments
     4.3 Patent Expiries
     4.4 Increasing Acceptance of Generics

5. Industry Performance
     5.1 Market Size and Growth
     5.2 Branded and Generics

6. Opportunities for Indian Generics Companies
     6.1 US
     6.2 Europe
     6.3 Japan
     6.4 Africa

7. Emerging Industry Trends

8. Regulatory Environment

9. Industry Restraints and Recommendations
     9.1 Counterfeit Drugs
     9.2 Lack of Promotional Initiatives
     9.3 Quality Issues

10. Competitive Landscape
     10.1 Industry Structure
     10.2 Key Players
              10.2.1 Ranbaxy
              10.2.2 Cipla Ltd.
              10.2.3 Jubilant
              10.2.4 Sun Pharmaceuticals
              10.2.5 Zydus Cadila
              10.2.6 Dr. Reddy's Laboratories
              10.2.7 Lupin Ltd.
              10.2.8 Aurobindo Pharma
              10.2.9 Glenmark Pharma
              10.2.10 Piramal Healthcare

Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.